A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer

[1]  A. Piccoli,et al.  Recurrence after resection for ductal adenocarcinoma of the pancreas , 1997, World Journal of Surgery.

[2]  Christopher H. Crane,et al.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration , 2004, Journal of Gastrointestinal Surgery.

[3]  Thomas J. Howard,et al.  Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head , 2003, Journal of Gastrointestinal Surgery.

[4]  L. Traverso.  Pancreatic cancer: surgery alone is not sufficient , 2006, Surgical Endoscopy And Other Interventional Techniques.

[5]  D. Sargent,et al.  A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. , 2005, Surgery.

[6]  M. Gonen,et al.  Long-Term Survival Is Superior After Resection for Cancer in High-Volume Centers , 2005, Annals of surgery.

[7]  J. Berlin,et al.  Treatment for pancreatic cancer: current therapy and continued progress. , 2005, Gastroenterology.

[8]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[9]  J. Izbicki,et al.  Mode of Spread in the Early Phase of Lymphatic Metastasis in Pancreatic Ductal Adenocarcinoma: Prognostic Significance of Nodal Microinvolvement , 2004, Annals of surgery.

[10]  H. Friess,et al.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.

[11]  Kathryn E. McGoldrick,et al.  Surgeon Volume and Operative Mortality in the United States , 2004 .

[12]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[13]  K. Akita,et al.  Innervation of the Pancreas from the Perspective of Perineural Invasion of Pancreatic Cancer , 2003, Pancreas.

[14]  J. Drebin,et al.  Radical antegrade modular pancreatosplenectomy. , 2003, Surgery.

[15]  L. Traverso,et al.  Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. , 2003, American journal of surgery.

[16]  D. Klimstra,et al.  Is extended resection for adenocarcinoma of the body or tail of the pancreas justified , 2003 .

[17]  C. Earle,et al.  Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients , 2003, Annals of surgery.

[18]  Birgir Gudjonsson,et al.  Survival Statistics Gone Awry: Pancreatic Cancer, a Case in Point , 2002, Journal of clinical gastroenterology.

[19]  M. Schäfer,et al.  Evidence-Based Pancreatic Head Resection for Pancreatic Cancer and Chronic Pancreatitis , 2002, Annals of surgery.

[20]  J. Werner,et al.  Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients. , 2001, Surgery.

[21]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[22]  M Manu,et al.  Molecular technology and pancreatic cancer , 2000, The British journal of surgery.

[23]  M. Farnell,et al.  Are the Results of Pancreatectomy for Pancreatic Cancer Improving? , 1999, World Journal of Surgery.

[24]  A. Andrén-sandberg,et al.  A Surgical and Pathological Based Classification of Resective Treatment of Pancreatic Cancer , 1999, Digestive Surgery.

[25]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[26]  K. Dhaene,et al.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. , 1998, Annals of surgery.

[27]  K. Lillemoe,et al.  Importance of hospital volume in the overall management of pancreatic cancer. , 1998, Annals of surgery.

[28]  A. Piccoli,et al.  Survival after resection for ductal adenocarcinoma of the pancreas , 1996, The British journal of surgery.

[29]  D. Klimstra,et al.  Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.

[30]  B. Gudjonsson.  Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting. , 1995, Journal of the American College of Surgeons.

[31]  J. Howard,et al.  Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. , 1995, Archives of surgery.

[32]  T. Colby,et al.  Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving? , 1995, Annals of surgery.

[33]  S. Houry,et al.  Results of resection for cancer of the exocrine pancreas: A study from the French Association of Surgery , 1994, The British journal of surgery.

[34]  A. Andrén-sandberg,et al.  Recurrence of exocrine pancreatic cancer--local or hepatic? , 1993, Hepato-gastroenterology.

[35]  N. Harada,et al.  Collective review of small carcinomas of the pancreas. , 1986, Annals of surgery.

[36]  D.,et al.  Regression Models and Life-Tables , 2022 .